EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Adjunctive Treatment with Subconjunctival and Topical Bevacizumab to Prevent Recurrence after Excision of Primary Pterygium: A Multi-centric Trial

Priyanka Pantola, Sandeep Gupta, Gagandeep Kaur, Pawan Kumar, Meenakshi Pathania, Priya Taank

Romanian Journal of Ophthalmology · 05.11.2026 · 70 (3)

DOI: 10.22336/rjo.2026.54 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Romanian Journal of Ophthalmology, online erschienen am 19.10.2026. Verfasst von Priyanka Pantola und 5 weiteren Autor:innen. Beteiligte Einrichtung: Command Hospital Air Force, Bangalore, India. Hauptthemen laut MEDLINE: Bevacizumab, Pterygium, Conjunctiva, Secondary Prevention. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BevacizumabPterygiumConjunctivaSecondary PreventionOphthalmologic Surgical ProceduresHumansFemaleAngiogenesis InhibitorsMaleMiddle AgedVisual AcuityFollow-Up StudiesVascular Endothelial Growth Factor ATreatment OutcomeRecurrenceOphthalmic SolutionsAdultTransplantation, AutologousAgedAdministration, Topical

Stichwörter der Autor:innen

5-FU = 5-FluorouracilBCVA = Best corrected visual acuityBVZ = BevacizumabCAG = Conjunctival autograftGAT = Goldmann Applanation tonometerHTFs = Human Tenon’s fibroblastsLCAT = Limbal conjunctival autograft transplantationLSCD = Limbal stem cell deficiencyMMP-1 = Matrix metalloproteinase-1VEGF = Vascular endothelial growth factorconjunctival autograftpterygiumrecurrence of pterygiumsubconjunctival bevacizumabtopical bevacizumab

Substanzen

BevacizumabAngiogenesis InhibitorsVascular Endothelial Growth Factor AOphthalmic Solutions

Autor:innen und Institutionen

  • Command Hospital Air Force, Bangalore, India.
  • Command Hospital (CC), Lucknow, India.
  • Military Hospital, Dehradun, India.
  • Akash Institute of Medical Sciences and Research Centre, Devenhalli, Bangalore, India.
  • Military Hospital, Jammu, India.
  • Command Hospital (NC), Udhampur, India.

Zitieren

APA

Pantola, P., Gupta, S., Kaur, G., Kumar, P., Pathania, M., & Taank, P. (2026). Adjunctive Treatment with Subconjunctival and Topical Bevacizumab to Prevent Recurrence after Excision of Primary Pterygium: A Multi-centric Trial. Romanian Journal of Ophthalmology, 70(3). https://doi.org/10.22336/rjo.2026.54

Vancouver

Pantola P, Gupta S, Kaur G, Kumar P, Pathania M, Taank P. Adjunctive Treatment with Subconjunctival and Topical Bevacizumab to Prevent Recurrence after Excision of Primary Pterygium: A Multi-centric Trial. Romanian Journal of Ophthalmology. 2026;70(3). doi:10.22336/rjo.2026.54

BibTeX
@article{Pantola2026,
  author = {Pantola, Priyanka and Gupta, Sandeep and Kaur, Gagandeep and Kumar, Pawan and Pathania, Meenakshi and Taank, Priya},
  title = {Adjunctive Treatment with Subconjunctival and Topical Bevacizumab to Prevent Recurrence after Excision of Primary Pterygium: A Multi-centric Trial},
  journal = {Romanian Journal of Ophthalmology},
  year = {2026},
  volume = {70},
  number = {3},
  doi = {10.22336/rjo.2026.54}
}
Kostenlos starten →